Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus: A Systematic Review and Meta-Analysis

OBJECTIVES: Proton pump inhibitors (PPIs) have been used for treatment of Barrett's esophagus (BE) for many years. However, the connection between PPIs and esophageal adenocarcinoma (EAC) in patients with BE has still been controversial. The current systematic review and meta-analysis was desig...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiang, Sun, Tian-Tian, Hong, Jie, Fang, Jing-Yuan, Xiong, Hua, Meltzer, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224998/
https://www.ncbi.nlm.nih.gov/pubmed/28072858
http://dx.doi.org/10.1371/journal.pone.0169691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224998/
https://www.ncbi.nlm.nih.gov/pubmed/28072858
http://dx.doi.org/10.1371/journal.pone.0169691

Ejemplares similares